-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Avibactam + Aztreonam) in Hospital Acquired Pneumonia (HAP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Avibactam + Aztreonam) in Hospital Acquired Pneumonia (HAP) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Avibactam + Aztreonam) in Hospital Acquired Pneumonia (HAP)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rogaratinib in Metastatic Transitional (Urothelial) Tract Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rogaratinib in Metastatic Transitional (Urothelial) Tract Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rogaratinib in Metastatic Transitional (Urothelial) Tract Cancer Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ricolinostat in Chronic Lymphocytic Leukemia (CLL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ricolinostat in Chronic Lymphocytic Leukemia (CLL) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ricolinostat in Chronic Lymphocytic Leukemia (CLL) Drug Details: Ricolinostat (ACY-1215)...
-
Product Insights
Changzhou EGing Photovoltaic Technology Co., Ltd. Solar PV Park
Changzhou EGing Photovoltaic Technology Co., Ltd. Solar PV Park is a solar PV project located in Jiangsu, China. The project is owned and developed by Changzhou EGing Photovoltaic Technology Co Ltd. The project is currently active. Empower your strategies with our Changzhou EGing Photovoltaic Technology Co., Ltd. Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Itacitinib Adipate in Non-Hodgkin Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Itacitinib Adipate in Non-Hodgkin Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Itacitinib Adipate in Non-Hodgkin Lymphoma Drug Details: Itacitinib adipate (INCB-39110)...
-
Company Insights
Innovation and Patenting activity of My EG Services Bhd Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of My EG Services Bhd Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Abemaciclib in Relapsed Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Abemaciclib in Relapsed Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Abemaciclib in Relapsed Multiple Myeloma Drug Details: Abemaciclib (Verzenio / Verzenios...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Trametinib Dimethyl Sulfoxide in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trametinib Dimethyl Sulfoxide in Endometrial Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trametinib Dimethyl Sulfoxide in Endometrial Cancer Drug Details: Trametinib (GSK1120212,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Trametinib Dimethyl Sulfoxide in Bile Duct Cancer (Cholangiocarcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trametinib Dimethyl Sulfoxide in Bile Duct Cancer (Cholangiocarcinoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trametinib Dimethyl Sulfoxide in Bile Duct Cancer (Cholangiocarcinoma)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EG-501 in Cognitive Impairment
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EG-501 in Cognitive Impairment report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.EG-501 in Cognitive ImpairmentDrug Details:EG-501 is under development for the treatment of cognitive...